Prospective Observational Lymphoedema Intensive Treatment (POLIT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01864044|
Recruitment Status : Completed
First Posted : May 29, 2013
Last Update Posted : May 29, 2013
The aim of this observational study was to describe usual practices in lymphedema management in France.
It was the opportunity to assess the effects of these practices on lymphedema volume in a large number of patients, to identify predictive factors of response, and to assess the safety of this therapy.
|Condition or disease|
Lymphoedema is commonly treated according a strategy called Complex Decongestive Therapy (CDT). This CDT is usually composed of 2 different treatment phases. The first phase is an acute phase which aim is to reduce affected limb volume. The second phase is a maintenance phase which aim is to maintain as long as possible the volume reduction acheived during the first phase.
These 2 phases required multi modal parameters such as bandages, lymphatic drainages, physical exercises...and can be managed very differently from one site to another.
|Study Type :||Observational|
|Actual Enrollment :||306 participants|
|Study Start Date :||September 2009|
|Actual Primary Completion Date :||March 2011|
- Change from baseline in affected limb volume [ Time Frame: At the end of 1st phase of Complex Decongestive Therapy and 6 months later ]According to the site, the first phase can lasts 1, 2 or 3 weeks.